Form 8-K - Current report:
SEC Accession No. 0001731122-25-000248
Filing Date
2025-02-19
Accepted
2025-02-19 08:45:21
Documents
13
Period of Report
2025-02-18
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6373_8k.htm   iXBRL 8-K 28018
  Complete submission text file 0001731122-25-000248.txt   204338

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE renb-20250218.xsd EX-101.SCH 3030
3 XBRL LABEL FILE renb-20250218_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE renb-20250218_pre.xml EX-101.PRE 24175
15 EXTRACTED XBRL INSTANCE DOCUMENT e6373_8k_htm.xml XML 3683
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 25637532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)